Medicine and Dentistry
Non Small Cell Lung Cancer
98%
Stereotactic Body Radiation Therapy
97%
Overall Survival
81%
Neoplasm
51%
Radiation Therapy
47%
Lung Cancer
40%
Lung
28%
Non-Small Cell Lung Cancer
21%
Recurrent Disease
20%
Quality of Life
19%
Lung Tumor
19%
Small Cell Lung Cancer
19%
Geriatric Assessment
19%
Geriatrics
19%
Thrombin
19%
Hazard Ratio
15%
Survival Rate
14%
Malignant Neoplasm
14%
Thrombocyte Aggregation
13%
Proportional Hazards Model
12%
Disease
11%
Chemotherapy
11%
Chemoradiotherapy
11%
Trachea
10%
Retrospective Study
10%
Hand Grip
9%
Consultation
9%
Hemispheric Dominance
9%
Pooled Analysis
9%
COVID-19
9%
Cross Sectional Study
9%
Telehealth
9%
Magnetic Resonance Imaging of the Brain
9%
Radiosurgery
9%
Stereotactic Radiosurgery
9%
Radiation Oncology
9%
Chronic Obstructive Pulmonary Disease
9%
Stereotactic Radiotherapy
9%
Rib Fracture
9%
Coronary Artery Calcium
9%
Comorbidity
9%
Bleeding
9%
Cancer Registry
7%
Chest
7%
Cross-Validation
6%
Patient Characteristics
6%
Log Rank Test
5%
Ex Vivo
5%
Bootstrapping
5%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Non Small Cell Lung Cancer
68%
Lung Cancer
62%
Malignant Neoplasm
49%
Neoplasm
38%
Recurrent Disease
21%
Small Cell Lung Cancer
19%
Comorbidity
19%
Survival Rate
18%
Cancer Registry
13%
Chemotherapy
11%
Chemoradiation Therapy
11%
Progression Free Survival
11%
Cross Sectional Study
10%
Retrospective Study
10%
Cross-Sectional Study
9%
Clinical Trial
9%
Thrombin
9%
Lung Tumor
9%
Messenger RNA
9%
Disease
8%
Pandemic
6%
Cross-Validation
5%
Nursing and Health Professions
Quality of Life
29%
Stereotactic Body Radiation Therapy
19%
Overall Survival
18%
Malignant Neoplasm
16%
Non Small Cell Lung Cancer
11%
Recurrent Disease
10%
Lung Cancer
10%
Geriatric Assessment
9%
Telehealth
9%
Survival Rate
9%
Radiotherapy
9%
Cross-Sectional Study
9%
Pandemic
6%
University Hospital
5%